![Dirk Kersten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Kersten
Directeur/Membre du Conseil chez
DYNE THERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
Mr. Dirk Kersten is an Independent Director at Dyne Therapeutics, Inc. and a Managing Partner at Forbion Capital Partners Management Holding BV.
He is on the Board of Directors at Dyne Therapeutics, Inc., NorthSea Therapeutics BV and Synox Therapeutics Ltd.
Mr. Kersten was previously employed as a Managing Director by INKEF Capital BV, a Partner by Gilde Healthcare Partners, Inc., a Director-Supervisory Board by Profibrix BV, and a Non-Executive Director by ViCentra BV.
He also served on the board at Ascendis Pharma A/S, Audion Therapeutics BV, GTx, Inc., Lanthio Pharma BV and NightBalance BV.
He received his graduate degree from the University of Groningen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Dirk Kersten
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2018 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01/10/2018 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Directeur/Membre du Conseil | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Dirk Kersten
| Sociétés | Poste | Fin |
|---|---|---|
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2018 |
Gilde Healthcare Partners, Inc.
 Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Directeur Général | 01/05/2014 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Directeur/Membre du Conseil | - |
NightBalance BV
 NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Directeur/Membre du Conseil | - |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Directeur/Membre du Conseil | - |
Formation de Dirk Kersten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Audion Therapeutics BV
 Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Discovers and deveops of drugs | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
NightBalance BV
NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Distribution Services |
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
ViCentra BV
 ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
